28402-17-7|WR 77913|Phosphorothioic acid, S-(3-amino-2-hydroxypropyl) ester, monosodium salt|-范德生物科技公司

WR 77913

NMR下载 COA and HPLC MSDS下载
names：
Phosphorothioic acid, S-(3-amino-2-hydroxypropyl) ester, monosodium salt
CAS号：
28402-17-7
MDL Number：
MF(分子式)： C3H9NNaO4PS MW(分子量)： 209.1315
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	Phosphorothioic acid, S-(3-amino-2-hydroxypropyl) ester, monosodium salt
英文别名	WR 77913; WR77913; WR-77913
CAS号	28402-17-7
SMILES	[O-]P(OC[C@@H](O)CN)(O)=S.[Na+]
Inchi	InChI=1S/C3H10NO4PS.Na/c4-1-3(5)2-8-9(6,7)10;/h3,5H,1-2,4H2,(H2,6,7,10);/q;+1/p-1/t3-;/m0./s1
InchiKey	UCTDNAFCGZFXLP-DFWYDOINSA-M
分子式 Formula	C3H9NNaO4PS
分子量 Molecular Weight	209.1315
闪点 FP
熔点 Melting point
沸点 Boiling point
Polarizability极化度
密度 Density
蒸汽压 Vapor Pressure
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	WR 77913(CAS:28402-17-7):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	WR 77913 is a radioprotective agent.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Spence AM, Krohn KA, Steele JE, Edmondson SE, Rasey JS. WR-2721, WR-77913 and WR-3689 radioprotection in the rat spinal cord. Pharmacol Ther. 1988;39(1-3):89-9[1]PubMed PMID: 2849135.

[2]Rasey JS, Magee S, Nelson N, Chin L, Krohn KA. Response of mouse tissues to neutron and gamma radiation: protection by WR-3689 and WR-77913. Radiother Oncol. 1990 Feb;17(2):167-73. PubMed PMID: 2157242.

[3] Mendiondo OA, Connor AM, Grigsby P. Sodium hydrogen-S-(3-amino-2-hydroxypropyl) phosphorothioate (WR-77913): toxicity and bone marrow radioprotection. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):553-5. PubMed PMID: 6286552.

[4] Menard TW, Osgood TB, Clark JI, Spence AM, Steele JE, Krohn KA, Livesey JC. Radioprotection against cataract formation by WR-77913 in gamma-irradiated rats. Int J Radiat Oncol Biol Phys. 1986 Aug;12(8):1483-6. PubMed PMID: 3019964.

[5] Clark JI, Livesey JC, Steele JE. Delay or inhibition of rat lens opacification using pantethine and WR-77913. Exp Eye Res. 1996 Jan;62(1):75-84. PubMed PMID: 8674515.

6: Remé CE, Braschler UF, Roberts J, Dillon J. Light damage in the rat retina: effect of a radioprotective agent (WR-77913) on acute rod outer segment disk disruptions. Photochem Photobiol. 1991 Jul;54(1):137-42. PubMed PMID: 1658823.7: Mendiondo OA, Connor AM, Grigsby P. Toxicity and radiation protective effect of WR-77913 in BALB/c mice. Acta Radiol Oncol. 1982;21(5):319-23. PubMed PMID: 6297251.8: Livesey JC, Wiens LW, Von Seggern DJ, Barlow WE, Arnold AM. Inhibition of radiation cataractogenesis by WR-77913. Radiat Res. 1995 Jan;141(1):99-104. PubMed PMID: 7997522.9: Dillon J, Kennedy JC, Pottier RH, Roberts JE. In vitro and in vivo protection against phototoxic side effects of photodynamic therapy by radioprotective agents WR-2721 and WR-77913. Photochem Photobiol. 1988 Aug;48(2):235-8. PubMed PMID: 2851844.10: Lam TT, Liu D, Brody MA, Chu R, Tso MO. Clearance of S-(3-amino-2-hydroxypropyl) phosphorothioate (WR-77913) in rats. Exp Eye Res. 1991 Jun;52(6):661-7. PubMed PMID: 1649765.1

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开